1. Home
  2. GLP vs MPLT Comparison

GLP vs MPLT Comparison

Compare GLP & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Partners LP

GLP

Global Partners LP

HOLD

Current Price

$49.26

Market Cap

1.6B

Sector

Energy

ML Signal

HOLD

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$27.54

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GLP
MPLT
Founded
2005
2018
Country
United States
United States
Employees
4700
133
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GLP
MPLT
Price
$49.26
$27.54
Analyst Decision
Hold
Strong Buy
Analyst Count
1
7
Target Price
$46.00
$32.67
AVG Volume (30 Days)
79.2K
249.6K
Earning Date
05-08-2026
05-28-2026
Dividend Yield
6.40%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$64.13
N/A
Revenue Next Year
$11.74
N/A
P/E Ratio
$23.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$39.58
$12.24
52 Week High
$56.51
$33.28

Technical Indicators

Market Signals
Indicator
GLP
MPLT
Relative Strength Index (RSI) 53.87 46.56
Support Level $45.18 $26.20
Resistance Level N/A $31.88
Average True Range (ATR) 1.67 2.22
MACD -0.08 -0.24
Stochastic Oscillator 50.27 38.99

Price Performance

Historical Comparison
GLP
MPLT

About GLP Global Partners LP

Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the GDSO segment.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: